Research Project

Measures for Improved Availability of medicines and vaccines (MIA)

Ensuring availability of essential medicines, vaccines and health commodities is one of today’s critical societal challenges


    • Wednesday, 21 July 2021 - MIA Master's theses at BI Norwegian Business School

      This spring, two master's theses have been written in connection with the MIA project at BI Norwegian Business School. Andreas Farstad Moe and Harald Wright have investigated how the Norwegian healthcare sector can improve its availability of antibiotics, while Hanne Bastholm and Shan Trau have examined how Norway can build a more resilient personal protective equipment (PPE) supply chain.

    • De Vries, H., Jahre, M., Selviaridis, K., van Oorschot, K. and Van Wassenhove, L.

      Paper accepted for publication:

      Short of Drugs? Call Upon Operations and Supply Chain Management (2021), forthcoming in International Journal of Operations and Production Management, DOI (10.1108/IJOPM-03-2021-0175).

    • Medicines supply and shortages: A UK perspective. Kostas Selviaridis & Nonhlanhla Dube

      This research seminar focused on the UK medicine supply system and provided an overview of issues and practices with respect to the management of supply and observed shortages. In the first part of our presentation we summarised the key issues emerging from our ongoing, exploratory research in the UK, both in ‘business-as-usual’ situations and in crisis events such as COVID-19 and Brexit.

      Read more (+)

      We highlighted a number of common themes across relevant UK stakeholders, including supply chain actors and other governmental and NHS England-affiliated organisations. We subsequently discussed a number of focused research projects to potentially undertake moving forward, all of which are informed by our engagement with UK stakeholders and our empirical research thus far. We concluded the seminar with a few thoughts on research methodology and design, notably the potential use of intervention-based research strategies to investigate specific aspects of the medicine shortages problem. Participants in the seminar contributed their comments, questions and reflections throughout, making it a highly interactive and fruitful event.

    • Hospital medicines pricing and procurement workshop

      Tendering systems are frequently being mentioned as a cause of drug shortages in high-income countries. The reasons include that tendering drives down prices and increases revenue uncertainty for market authorization holders (MAHs) of medicines. This, in turn, drives many MAHs out of the market and disincentivizes them to invest in inventories, slack production, and production quality. Each of these consequences enhances the risk of drug shortages.

      Read more (+)

      The question that arises is: how might we redesign a tendering system in such a way that it strikes the right balance between affordability (i.e., the capability of the tendering system to keep prices low) and availability (i.e., the capability of the tendering system to attract a diverse and reliable supply base)?

      To address this question, MIA researchers Christine Årdal (Norwegian Institute of Public Health), Harwin de Vries (Rotterdam School of Management), Dag Morten Dalen (BI Oslo), and Kostas Selviaridis (Lancaster University) organized a seminar with experts on the hospital medicines tendering systems in Belgium (Thomas de Rijdt), Denmark (Flemming Sonne), France (Jonathan Rodrigues), Norway (Eirik Sverrisson), Sweden (Ulf Törnqvist) and The Netherlands (Peter Dohmen, Prof. Erik van Raaij), which took place on April 8th, 2021. The participants shared how the system in their country works and discussed how the characteristics of these systems affect drug shortages. The latter include the level of centralization, the number of winners, and the duration of the contracts. The findings will form the basis for research on the link between tendering and shortages and optimal tendering system design.

    • Short of Drugs? Contributions from Operations and Supply Chain Management

      Professor Marianne Jahre and Dr Joe Viana were invited to give a seminar at the Indian Institute of Management Kozhikode on 25.02.21. The seminar entitled “Short of Drugs? Contributions from Operations and Supply Chain Management” presented the Measures for Improved Availability of medicines and vaccines (MIA) project and the related COVID-19 Supply Chain Task project with some initial results.


    • Mapping workshop: for the researchers involved in the COVID project

      25 November: The purpose of the workshop was to provide each other with knowledge on how to map supply chains, what data and tools are available, and the specifics of the Ethiopian context. Participating presenters included Marianne Jahre, Tsegaye Melaku and Emily Gooding.

    • Friday, 30 October 2020 - Seminar Kriseledelse og krisehåndtering

      Verden har opplevd en situasjon helt utenom det vanlige og helsevesenet har vært spydspissen i håndteringen av covid-19. Hva har vi lært og hva kan vi bruke det til?

    • Wednesday, 02 September 2020 - BI Business Review Hvordan sikre forsyninger mot neste krise

      I en global verden, blir forsyningskjedene i samfunnet mer ustabile, usikre, komplekse og vanskelige å forutsi. Hvordan kan organisasjoner sikre sine forsyninger bedre?

    • Monday, 31 August 2020 - Bedre legemiddeltilgang med Netflix-metoden?

      Jeg er ikke lenger sikker på at Netflix-metoden vil trylle bort dilemmaet med at ikke alle får bruke nye effektive legemidler. Det er langt fra desentralisert og prisfølsom seeratferd for filmer og serier til sentraliserte forhandlinger om finansiering og bruk av nye legemidler.

    • Thursday, 02 July 2020 - New Master of Science in Crisis Management

      Crisis management is an interdisciplinary research field that seeks to understand and guide how organizations can prepare for and respond to such events. This field draws from numerous disciplines including strategy, communication science, organizational behavior and leadership, business continuity and supply chain research, and is sometimes referred to as disaster and/or risk management. The field is more important than ever.

    • Thursday, 02 July 2020 - Crisis management Summer course hosted by MIA researchers

      BI recently kicked off the annual summer school programme. Under the special circumstances of the coronavirus affecting worldwide mobility, this year’s summer school was like no other. This year, 70 students from BI was enrolled to a special course on crisis management, with a special emphasis on covid-19.

    • Thursday, 25 June 2020 - Digital seminar on state-of-the-art research on the ongoing coronavirus pandemic

      MIA project leader, Professor Marianne Jahre, met with the Norwegian minister of development, Dag Inge Ulstein, in a digital seminar on state-of-the-art research on the ongoing coronavirus pandemic. During the meeting, hosted by the Norwegian Research Council, Prof. Jahre presented the MIA project and the ongoing work in the covid-19 Task Forces. She presented some of the initial findings on how to mitigate and cope with shortages in medical supplies as well as how one could prevent similar situations in the future. She also pinpointed a few important development aspects relevant to the MIA-partner institutions in Ethiopia, Jimma University and St. Paul’s Hospital Millenium Medical College.

    • Thursday, 18 June 2020 - Tungt Logistikk LOGMA: How to Succeed with Logistics in Crisis

      In a recent article, MIA-researcher Marianne Jahre argues they can and describes how to best go at it as we deal with the fallout from the ongoing pandemic (in Norwegian).

    • Saturday, 30 May 2020 - Successful inaugural meeting for the MIA Project

      In a novel approach, the digital project meeting gathered more than 25 researchers, practitioners and master students from six different countries in an online conference room through Zoom.

    • Friday, 03 April 2020 - Harvard Business Review A Covid-19 Vaccine Will Need Equitable, Global Distribution

      With the development of potential vaccines for Covid-19 progressing quickly, we need to invest now in infrastructure for distributing a vaccine globally on an equitable basis as soon as it is proven safe and effective. Article by MIA-research partner Prashant Yadav in INSEAD’s Humanitarian Research Group in the Harward Business Review.